Back
Edgewise Therapeutics Stock Price Chart
Sponsored
EWTX
Sponsored
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
73
EWTX
Edgewise Therapeutics
Last Price:
33.35
Seasonality Move:
40.09%
7 Day Trial
ALL ACCESS PASS
$
7
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.- The current trend is moderately bullish and EWTX is experiencing slight buying pressure.
Edgewise Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.71 | Sell |
20-day SMA: | 31.78 | Buy |
50-day SMA: | 25.15 | Buy |
200-day SMA: | 19.47 | Buy |
8-day EMA: | 34.16 | Buy |
20-day EMA: | 31.8 | Buy |
50-day EMA: | 27.11 | Buy |
200-day EMA: | 19.73 | Buy |
Edgewise Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.87 | Buy |
Relative Strength Index (14 RSI): | 68.31 | Buy |
Chaikin Money Flow: | 75029 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.05 - 34.23) | Buy |
Bollinger Bands (100): | (16.02 - 27.7) | Buy |
Edgewise Therapeutics Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 34.44 while EWTX 8-day simple moving average is 34.71, which is a Sell signal.
- The stock price of EWTX is 34.44 while Edgewise Therapeutics 20-day SMA is 31.78, which makes it a Buy.
- Edgewise Therapeutics 50-day simple moving average is 25.15 while EWTX share price is 34.44, making it a Buy technically.
- EWTX stock price is 34.44 and Edgewise Therapeutics 200-day simple moving average is 19.47, creating a Buy signal.
EWTX Technical Analysis vs Fundamental Analysis
Buy
73
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a Buy
The current Edgewise Therapeutics [EWTX] share price is $34.44. The Score for EWTX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
3.23B
Price in USD:
34.44
Share Volume:
546.64K
Edgewise Therapeutics 52-Week Range
52-Week High:
36.66
52-Week Low:
5.12
Buy
73
Edgewise Therapeutics (EWTX)
is a Buy
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?
The Edgewise Therapeutics stock price is 34.44 USD today. -
Will EWTX stock go up or go down?
Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Edgewise Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is not overvalued.
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 34.44 while EWTX 8-day exponential moving average is 34.16, which is a Buy signal.
- The stock price of EWTX is 34.44 while Edgewise Therapeutics 20-day EMA is 31.80, which makes it a Buy.
- Edgewise Therapeutics 50-day exponential moving average is 27.11 while EWTX share price is 34.44, making it a Buy technically.
- EWTX stock price is 34.44 and Edgewise Therapeutics 200-day simple moving average is 19.73, creating a Buy signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.35 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
- EWTX Moving Average Covergence Divergence (MACD) indicator is 2.87, suggesting Edgewise Therapeutics is a Buy
- Edgewise Therapeutics Relative Strength Index (RSI) is 68.31, which suggest Edgewise Therapeutics is overbought
- The Bollinger Bands (25) for Edgewise Therapeutics is (27.05 - 34.23), which suggest Edgewise Therapeutics is a Buy
- The Bollinger Bands (100) for Edgewise Therapeutics is (16.02 - 27.7), which suggest Edgewise Therapeutics is a Buy
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.